Not to long ago, the news was filled with information on the recall of the popular heartburn medication, Zantac. The FDA reported that concerning amounts of NDMA were found in the drug. This discovery prompted the recall of thousands of Zantac, and its generics. Recently, this substance has been now found in some type 2 diabetes medication. Pharmaceutical companies such as Teva, Marksans, Apotox, and Amneal have now issued recalls for many of their type 2 diabetes medications.

This week, two more pharmaceutical companies issued their own recalls of their medication. Lupin has issued a recall for its Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 1000 mg. Granules Pharmaceuticals has also recalled 12 lots of its Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count drugs. Metformin is a prescription medication that is used “to improve blood glucose control in adults with Type 2 diabetes mellitus. The FDA has advised those affected to speak with their medical provider before they stop taking their prescription. A sudden stop could be dangerous to those who have serious conditions. Below is a detailed list of the of recalls from the two previously mentioned companies.

RECALLED

LUPIN PHARMACEUTICALS Metformin Hydrochloride Extended-Release Tablets USP

500 mg, NDC No. 68180-338-01, distributed between Nov. 21, 2018, and May 27, 2020.

1000 mg, NDC No. 68180-339-09, distributed between Nov. 21, 2018, and May 27, 2020.

500 mg, NDC No. 68180-336-07, distributed between Nov. 5, 2018, and May 22, 2020.

1000 mg, NDC No. 68180-337-07, distributed between Nov. 5, 2018, and May 22, 2020.

The medication was distributed in bottles of 60, 90, and 100 tablets and was distributed nationwide in the United States to wholesalers, distributors, drug chain, mail-order pharmacies, and supermarkets.

For more information, call Inmar Rx Solutions, Inc. at 855-532-1856, between 9 a.m. and 5 p.m. EST, weekdays.

GRANUELS PHARMACEUTICALS

Metformin Hydrochloride Extended-Release Tablets USP, 750 mg

100 count bottles, NDC No. 70010-492-01, Lot numbers and expiration dates – 4920003A/May 2021, 4920004A/June 2021, 4920005A/June 2021, 4920009A/November 2021, 4920010A/May 2022, 4920011A/June 2022, 4920012A/June 2022, 4920013A/July 2022, 4920014A/July 2022, 4920015A/August 2022 and 4920016A/January 2023.

500 count bottles, NDC No. 70010-492-05, lot No. 4920005B, expires June 2021.

Injured by Someone’s Negligence? Contact The Law Giant

At The Law Giant, Personal Injury & Accident Lawyers, we understand how traumatic events like this can be. That’s why we are committed to helping victims recover compensation through personal injury lawsuits. If you have been injured and negligence may have caused the injury, you should promptly talk to an attorney with experience in personal injury and negligence cases. Your lawyer will know what your rights are under the law. You may be entitled to compensation. contact our firm today at (866) 523-4167 to schedule a free, initial evaluation of your case.

Related Posts

The Link Between DCPA Exposure & Birth Defects in Texas

How to Properly Document Property Damage for an Insurance Claim After a Hurricane or Storm

Texas Pool Safety Essentials: Preventing Pool Drownings for TX Families

"*" indicates required fields

Free Consultation | No Fee Until We Win!

Notice*
Read DisclaimerBy checking the box above, I give my express written consent to receive SMS messages regarding my legal inquiry, including updates, reminders, and promotional content. I understand this includes providing my phone number and other details I voluntarily share via this website's contact form or SMS messages. Information collected may include personal data (name, phone number, email, state), web server logs (IP address, ISP, geographic location, browser type), and cookies/tracking technologies (preferences, site usage). Each SMS will include opt-out options. Providing consent for SMS messages does not affect my ability to obtain legal services. MSG and Data Rates may apply. I acknowledge that I have read and agree to the privacy policy, particularly the Collection and Use of Personal Information section.